SCHEMBL6173899

SCHEMBL6173899

CC(c1ccncc1C(=O)Oc1ccccc1)C1(C(C)c2ccncc2C(=O)Oc2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 1/20 0.36
CXCR3 P49682 3/20 0.34
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
LIPE Q05469 1/20 0.33
OPRL1 P41146 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
AHR P35869 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TRPV1 Q8NER1 1/20 0.33
ATP1A1 P05023 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172522 0.90 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172569 0.89 IGF1R (0.36) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6171994 0.88 ALDH1A1 (0.37) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6175486 0.88 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174636 0.87 ALDH1A1 (0.41) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174774 0.87 SLC5A1 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6175907 0.87 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172003 0.85 ALDH1A1 (0.37) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6174812 0.84 ALDH1A1 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172844 0.83 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed